Catalyst Wire Dossier Catalyst Wire Dossier

MNRP1685A

· Genentech, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MNRP1685A, covering 2011-04-20 to 2017-05-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MNRP1685A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]

See pricing